Skip to main content
Retour
Watch Compare

ALX ONCOLOGY HOLDINGS INC

Qualité des données : 83%
ALXO
NASDAQ Manufacturing Chemicals
1,62 €
▼ 0,14 € (-7,71%)
6 months return
—
Momentum
Neutral
ROE
-186,23%

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-186,23%
En dessous de la moyenne du secteur (-54,49%)
ROIC-125,01%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
0,24
En dessous de la moyenne du secteur (0,30)
Current Ratio2,40
Interest Coverage-64,93

Valorisation

PE (TTM|NTM)
-2,20 | -2,77
En dessous de la moyenne du secteur (-1,50)
P/B Ratio4,99
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Debt/Equity of 0,24 — conservative balance sheet
Negative free cash flow of -84,35 M

Price History

Tendances Financières

Objectif de Cours des Analystes

5 analystes
Buy
+184.8%
upside to target
Actuel
1,62 €
Consensus Target
4,60 €
4,00 €
Bas
6,00 €
Haut
Prévisions
P/E Prévisionnel
-2,77
BPA Prévisionnel
-0,61 €
CA Est.
0,0

Surprises de Résultats

EPS
Reported Estimate Forecast
Next: Q1 2026 · EPS Est: -0,16 € · Rev Est: 0,0
Q12025 Q22025 Q32025 Q42025 Q1 '26 Q2 '26
Reported -0,48 € -0,44 € -0,41 € -0,37 € — —
Estimate -0,31 € -0,31 € -0,37 € -0,32 € -0,16 € -0,16 €
Surprise -54,47% -43,10% -10,07% -15,54% — —

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: -186,23% · Net Margin: N/A
Revenue (TTM) N/A Net Income (TTM) -101,70 M
ROE -186,23% ROA -114,24%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -84,35 M
ROIC -125,01% FCF Growth (3Y) N/A

Safety

D/E: 0,24 · Current: 2,40
Debt / Equity 0,24 Current Ratio 2,40
Interest Coverage -64,93 Asset Turnover N/A
Working Capital 38,79 M Tangible Book Value 44,80 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -2,20 · EV/EBITDA: N/A
P/E Ratio -2,20 Forward P/E -2,77
P/B Ratio 4,99 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -37,70%
Market Cap 223,73 M Enterprise Value 210,89 M

Per Share

EPS: -1,90 · FCF/Share: -0,64
EPS (Diluted TTM) -1,90 Revenue / Share N/A
FCF / Share -0,64 OCF / Share -0,64
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 82,95% · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion 82,95%
SBC-Adj. FCF -101,18 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — 0,0 1,18 M
Net Income -101,70 M -134,85 M -160,81 M -123,48 M -83,46 M
EPS (Diluted) -1,90 -2,58 -3,74 -3,03 —
Gross Profit — — — — —
Operating Income -104,02 M -142,47 M -170,28 M -127,44 M -83,56 M
EBITDA — — — — —
R&D Expenses 77,00 M 116,37 M 141,80 M 98,40 M 60,17 M
SG&A Expenses — — — — —
D&A 706 000,0 872 000,0 836 000,0 342 000,0 51 000,0
Interest Expense 1,60 M 1,73 M 1,57 M — —
Income Tax 0,0 64 000,0 64 000,0 64 000,0 -21 000,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 59,05 M 147,78 M 242,55 M 306,49 M 380,18 M
Total Liabilities 33,07 M 34,16 M 52,84 M 43,03 M 17,13 M
Shareholders' Equity 25,98 M 113,62 M 189,71 M 263,46 M 363,05 M
Total Debt 10,17 M 10,60 M 10,60 M 10,60 M —
Cash & Equivalents 16,37 M 17,57 M 22,41 M 48,82 M 363,67 M
Current Assets 50,73 M 134,35 M 188,66 M 270,97 M 367,02 M
Current Liabilities 24,55 M 18,50 M 36,00 M 28,33 M 15,30 M

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1605 pairs)
Métrique Action Médiane du Secteur
P/E -2,2 -1,5
P/B 5,0 1,6
ROE % -186,2 -54,5
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E 0,2 0,3

ETFs Holding This Stock
BRUSX BRUSX
0,02% weight